E-Mail
LOS ANGELES (February 10, 2021) The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness. The grant will also support education and outreach programs related to the use of psilocybin within the field of palliative care. This innovative and first-of-its-kind psychedelic study will be conducted at several leading medical schools and cancer centers across the United States, including Harbor-UCLA Medical Center. This project has the potential to help so many people during one of the most stressful times in a person s and family s life, said Alexandra Cohen, President, Steven & Alexandra Cohen Foundation. We are pleased to support the Lundquist Institute in their efforts to explore the benefits of psychedelics for patients with terminal
E-Mail
IMAGE: Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death view more
Credit: Julio Alencar
Lung ultrasound, considered a simple method for diagnosing lung disease, can also help predict the clinical progression of severe COVID-19 patients, according to a study conducted at the University of São Paulo s Medical School (FM-USP) in São Paulo City, Brazil.
The principal investigator for the study was Heraldo Possolo de Souza, a professor at FM-USP and an attending physician at its teaching and general hospital, Hospital das Clínicas (HC).
The researchers applied an ultrasound examination protocol covering 12 lung regions in 180 COVID-19 patients undergoing treatment at HC. The results showed that the higher the lung ultrasound score, the greater the risk of admission to an intensive care unit (ICU), intubation, and death.
Intensive care nurses highlight patient isolation, fear of the unknown and using nurses who do not usually work in the ICU as key factors in caring for critical COVID-19 patients
E-Mail
IMAGE: Todd Vogel, MD, associate professor of vascular and endovascular surgery at the University of Missouri School of Medicine view more
Credit: Justin Kelley, MU Health Care
Ruptured abdominal aortic aneurysms (rAAA) are responsible for nearly 2% of all deaths in U.S. men over the age of 65. Endovascular aneurysm repair (EVAR) has emerged as a newer and less invasive alternative to open repair for rAAA, and current guidelines recommend EVAR as a first-line option for treatment of rAAA when certain criteria are met. But researchers from the University of Missouri School of Medicine have discovered that while EVAR is more commonly utilized for rAA, shortens hospital stay and has a lower initial mortality rate, the odds of hospital readmission after EVAR are 1.5 times higher compared to traditional open repair.
Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM
DES PLAINES, IL The combination of a high-dose NSAID with paracetamol does not increase the analgesic effect compared to paracetamol alone. Researchers also found that paracetamol alone is superior to high-dose NSAID alone for posttraumatic extremity pain. These are the findings of a study titled Acetaminophen, or nonsteroidal anti-inflammatory drugs, or combination of both analgesics in acute post-trauma pain: a randomized controlled trial, to be published in the February 2021 issue of
Academic Emergency Medicine (
AEM), a journal of the Society for Academic Emergency Medicine (SAEM).